Wutah bathi EPS kuartalan kerostx.com (KROS)

Simbol lan logo merek Keros Corp (KROS)

Quarterly EPS dynamics demonstrate market confidence in stable leadership advancing research into rare pathologies. Profit growth is based on future sales of anemia and bone disease therapies, as well as partnerships with scientists to study tissue regeneration. The current mark 488.40 indicates the level of the fundamental state of Keros Therapeutics (KROS), confirming the company's development vector.

KROS: Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan Keros Therapeutics, Inc. 04.07.2022 - 18.11.2026

Keros Therapeutics (KROS) - rincian metrik lan laporan keuangan

- rega saham lan prakiraan rega para ahli:
Analisis wiwitan perusahaan:Keros Therapeutics
Barang unggulan Keros Corp

Keros Therapeutics (KROS) is scaling its business by patenting high-margin hematological drugs. The current quarterly EPS trend on the GURU.Markets platform reflects the effectiveness of this strategy. This metric measures the percentage change in net income per share, revealing the actual profitability of the business. The growth of this metric confirms the successful monetization of scientific investments. A steady increase in EPS serves as a signal of fundamental stability for long-term investors.

Karo sapa Keros Therapeutics saingan

VRTX: Wutah bathi EPS kuartalan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan Alnylam Inc. (ALNY)|INSM (Insmed) - Wutah bathi EPS kuartalan|Wutah bathi saben saham taun-ka-taun sajrone 12 wulan pungkasan UTHR (United Therapeutics Corporation)|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan BMRN (BioMarin)|BBIO (BridgeBio Pharma) - Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan|Wutah bathi EPS kuartalan BGM (BGM Group Ltd)|COGT (Cogent Bio) - Dinamika bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan|Xeris Biopharma - Wutah bathi EPS kuartalan|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan ARCT (Arcturus Therapeutics)|ETON: Wutah bathi EPS kuartalan|Kamada Ltd (KMDA) - Wutah bathi EPS kuartalan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan Fulcrum Tx|ABEO: Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan Mereo BioPharma Group (MREO)|Wutah bathi EPS kuartalan protalix.com (PLX)|Wutah bathi EPS kuartalan PLRX (Pliant Therapeutics Inc)|Wutah bathi EPS kuartalan Applied Therapeutics APLT|RNTX - Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|Wutah bathi resik saben saham sajroning taun lumaku gelteq.com (GELS)|AYTU (aytubio.com) - Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|Chemomab Therapeutics Ltd - Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan SRXH|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan PLRZ|Wutah bathi EPS kuartalan AEZS|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan CYTH (Cyclo Therapeutics, Inc)|Inozyme Pharma - Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|Reneo Pharmaceuticals, Inc. (RPHM) - Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan|COSCIENS Bio - Wutah bathi EPS kuartalan